The development of the individual TQC guidelines, this one included, is spearheaded by expert reviewers and involves broad stakeholder input from the medical physics and radiation oncology community. 4 It is the responsibility of the supervising physicist to ensure that locally available test equipment and procedures are sufficiently sensitive to establish compliance with the criteria specified within the suite of TQC guidelines. Even if an accurate algorithm and accurate beam models are employed, the system can be misused resulting in serious detriment to patients. 7 Such misuse often arises from a lack of understanding of the basis of the calculations, and in particular, issues to do with dose normalization. It is important to recognize that a random dosimetric or transcription error at the planning stage will be transmitted through the whole course of a patient's treatment. A systematic problem with the algorithm, beam model, or understanding of the use of the system has the potential to affect a cohort of patients. 8 Due to the critical and central nature of the TPS in the treatment process, extensive commissioning and quality control are essential. Given the complex interdependence between the system and operators, the quality control process must extend to a detailed review on a per-patient basis. Intensity-modulated radiation therapy (IMRT), and most recently intensitymodulated arc therapy (IMAT), and adaptive radiotherapy (ART), are particularly specialized and resource-intensive applications of treatment planning and delivery systems. Quality control as it relates to IMRT, IMAT, and ART will be covered in separate Technical Quality Control (TQC) guideline documents (available at www.cpqr.ca).
The complexity of TPSs and the processes and interactions which surround them require a more detailed discussion than can be given here. The focus of this document is contained in Tables 1 and   2 and their associated notes which specify the routine quality control standards to be followed. More detailed descriptions of TPSs and in particular, commissioning activities and quality assurance, can be found in the source document 9 and other related references.
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It should be noted that specialized TPSs are sometimes used for specific applications. Examples include high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy with radioactive seeds, stereotactic radiosurgery, helical tomotherapy, and Gamma
Knife. In such cases where a specialized TPS is used, the principles of quality assurance and quality control espoused in this report, although modified for the specific situation, should be applied. It is worth noting that the rapid evolution of radiation treatment technologies presents significant challenges on the quality assurance and quality control of TPSs. Some of these challenges are related to the dose optimization processes and their corresponding algorithms (as used in IMRT), dose reconstruction, four-dimensional calculations, treatments and all their associated phantoms, and quality assurance tools. 
| TPS TEST TABLES
The following test tables are divided into quarterly and annual quality control tests. These tests are designed to cover the minimum rec- ). The system should be checked if error message is displayed during the rebooting process. Document the error message and fix. For a multiple-user TPS running on a server(s), rebooting may not be recommended. However, server log files shall be reviewed and error messages investigated and fixed as required. After a software or hardware upgrade of the workstations or server (s) associated with the TPS, a quarterly quality control shall be performed. Revalidation is required for a major upgrade (e.g., involving a new operating system or a new user-server(s) communication platform)
QTPS2
Using the onscreen ruler, check that a known contour has been digitized accurately (see more information in IAEA ). If this test requires a parallel TPS to be safely conducted and such parallel system is not available, a set of patient files from the clinical TPS shall be compared to the corresponding backup patient files
QTPS7
Check that the CT geometry and the relationship between CT number and density have not changed. Tolerances and action levels are specified in millimeters/relative electron density. ). For each type of plan, the testing shall include the most extreme scenarios likely to be encountered clinically. As part of the constancy check, the repeatability of the calculated dosevolume histogram (DVH) shall be reviewed. Consistency between calculated percentage depth doses (PDD) and tissuephantom ratios (TPR), open, blocked, and wedged fields dose profiles shall be compared with the corresponding beam data used for the TPS commissioning. Calculation must be performed using the clinical mode of the TPS. Test the treatment planning process from end-to-end under the most realistic circumstances: CT scan and plan an anthropomorphic phantom using the immobilization devices used clinically. Treat the phantom in clinical mode including usual imaging; verify the measured to plan-dose agreement by comparing it with baseline TPS commissioning data ATPS2 To ensure redundancy and adequate monitoring, a second qualified medical physicist must independently verify the implementation, analysis, and interpretation of the quality control tests at least annually
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